VANTALA Trademark

Trademark Overview


On Friday, October 22, 2021, a trademark application was filed for VANTALA with the United States Patent and Trademark Office. The USPTO has given the VANTALA trademark a serial number of 79327142. The federal status of this trademark filing is REGISTERED as of Tuesday, May 9, 2023. This trademark is owned by Kira Biotech Pty Limited. The VANTALA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, clinical research and development services of monoclonal antibodies; advisory and consultancy services relating to scientific research, clinical research and development services of monoclonal antibodies; scientific research; scientific research consultancy; provision of scientific information in the field of monoclonal antibodies; scientific research and technical analysis in the field of monoclonal antibodies; medical research; pharmaceutical research; research and development of products; research and development relating to pharmaceuticals, medicines, and drugs; scientific research and development services for pharmaceutical, veterinary, and medical purposes; advisory and consultancy services relating to scientific research and development services for pharmaceutical, veterinary, and medical purposes; scientific research, clinical research and development services in relation to pharmaceutical, medicinal, and veterinary drugs, and preparations comprising the sa...
vantala

General Information


Serial Number79327142
Word MarkVANTALA
Filing DateFriday, October 22, 2021
Status700 - REGISTERED
Status DateTuesday, May 9, 2023
Registration Number7045338
Registration DateTuesday, May 9, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements


Translation of Words in MarkThe wording "VANTALA" has no meaning in a foreign language.
Goods and ServicesScientific research, clinical research and development services of monoclonal antibodies; advisory and consultancy services relating to scientific research, clinical research and development services of monoclonal antibodies; scientific research; scientific research consultancy; provision of scientific information in the field of monoclonal antibodies; scientific research and technical analysis in the field of monoclonal antibodies; medical research; pharmaceutical research; research and development of products; research and development relating to pharmaceuticals, medicines, and drugs; scientific research and development services for pharmaceutical, veterinary, and medical purposes; advisory and consultancy services relating to scientific research and development services for pharmaceutical, veterinary, and medical purposes; scientific research, clinical research and development services in relation to pharmaceutical, medicinal, and veterinary drugs, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders; advisory and consultancy services relating to scientific research, clinical research and development services in relation to pharmaceutical, medicinal, or veterinary drugs, and preparations comprising the same, for the treatment, management, diagnosis, and prevention of immune system disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 3, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKira Biotech Pty Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameKira Biotech Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameKira Biotech Pty Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Monday, September 4, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 14, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 14, 2023FINAL DISPOSITION PROCESSED
Wednesday, August 9, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, May 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 9, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 9, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 1, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 23, 2022REFUSAL PROCESSED BY IB
Wednesday, August 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 3, 2022REFUSAL PROCESSED BY MPU
Tuesday, August 2, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 1, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022ASSIGNED TO EXAMINER
Tuesday, December 7, 2021APPLICATION FILING RECEIPT MAILED
Friday, December 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB